You are here

Jill Gormley
 - ICD - David B. DeLurgio, MD
Cardiovascular Business

Implantable cardioverter-defibrillators (ICDs) are true lifesavers, but like all devices, their components potentially can malfunction. The natural life of a well-performing ICD lead, for instance, is about 10 years or so but several models of leads have higher rates of failure. Properly managing a patient with a failing lead or a recalled lead is a clinical challenge.

 - blood test, diabetes, C-reactive protein
Cardiovascular Business

The mean pregnancy-associated plasma protein A (PAPP A) levels of patients who presented with chest pain at a hospital were higher in patients who went on to have a cardiovascular event within 90 days than in patients who did not have an event.

 - Heart
Cardiovascular Business

Treating heart failure with angiotensin-converting enzyme (ACE) inhibitors, beta-blockers and aldosterone antagonists provided the largest gains in quality-adjusted life years compared with treatments that did not include all three agents. Treatment according to guidelines resulted in an incremental cost-effectiveness ratio of less than $1,500 per quality-adjusted life year.

 - Stroke, endovascular. neuroimaging, neuro
Cardiovascular Business

A bedside device that can calibrate subtle eye and head movements may be key to correctly diagnosing strokes in patients who present with dizziness, nausea, nystagmus, unsteady gait and head movement intolerance.

 - ICD
Cardiovascular Business

Combining research-derived data, practice guidance and common clinical experience, the American College of Cardiology Foundation, the Heart Rhythm Society and other specialty societies released appropriate use criteria (AUC) for implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy.

 - Wyoming flag
Cardiovascular Business

Wyoming hospitals that achieve accreditation by nationally recognized accrediting bodies for care of STEMI and stroke will now receive public recognition from the Wyoming Health Department. In what an American Heart Association (AHA) official called “a great first step,” Wyoming Gov. Matt Mead signed a bill requiring the public recognition on Feb. 28.

 - Smiling Faces of Children
Cardiovascular Business

Day-of-surgery admissions, early extubation and mobilization in pediatric surgeries to correct congenital heart defects (CHDs) reduce costs of admissions by a third, with no increase in morbidity and mortality, according to a study published online Feb. 26 in Circulation: Cardiovascular Quality and Outcomes.

 - Women Be Jogging
Cardiovascular Business

Predicting atrial fibrillation (AF) risk in otherwise healthy women with no known cardiovascular disease may require only easily obtainable information that is readily available to physicians and other healthcare practitioners, according to a study published online Feb. 26 in the European Heart Journal.

 - The OR Goes Green
Clinical Innovation + Technology

Hospitals produce enormous quantities of waste and consume energy 24/7. Forward-thinking providers make improving environmental performance a priority because it is the right thing to do, and also because waste reduction and energy conservation increases efficiency and cost-effectiveness. Operating rooms (ORs), with disproportionately large environmental footprints, are one place where a few thoughtful changes can make a huge impact.

 - Paperless
Cardiovascular Business

EHRs lighten administrative burden, but practices must roll out implementation carefully and anticipate bumps in the road.